Yung WK - Search Results

1

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.

Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D. Saito N, et al. Among authors: yung wk. Stem Cells. 2014 Jan;32(1):301-12. doi: 10.1002/stem.1528. Stem Cells. 2014. PMID: 24038660 Free PMC article.

2

Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.

Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Sheng X, et al. Among authors: yung wk. Biochem Biophys Res Commun. 2002 Mar 29;292(2):422-6. doi: 10.1006/bbrc.2002.6662. Biochem Biophys Res Commun. 2002. PMID: 11906179

3

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.

Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Koul D, et al. Among authors: yung wk. Oncogene. 2002 Apr 4;21(15):2357-64. doi: 10.1038/sj.onc.1205296. Oncogene. 2002. PMID: 11948419

4

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.

Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. Koul D, et al. Among authors: yung wk. Int J Oncol. 2002 Sep;21(3):469-75. Int J Oncol. 2002. PMID: 12168088

5

Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.

Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Lang FF, et al. Among authors: yung wk. Neuro Oncol. 2002 Oct;4(4):268-77. doi: 10.1093/neuonc/4.4.268. Neuro Oncol. 2002. PMID: 12356357 Free PMC article.

6

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Fueyo J, et al. Among authors: yung wk. J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652. J Natl Cancer Inst. 2003. PMID: 12734316

7

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Lang FF, et al. Among authors: yung wk. J Clin Oncol. 2003 Jul 1;21(13):2508-18. doi: 10.1200/JCO.2003.21.13.2508. J Clin Oncol. 2003. PMID: 12839017 Clinical Trial.

8

Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Lu Y, et al. Among authors: yung wk. J Biol Chem. 2003 Oct 10;278(41):40057-66. doi: 10.1074/jbc.M303621200. Epub 2003 Jul 17. J Biol Chem. 2003. PMID: 12869565 Free article.

9

Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.

Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ. Cerrato JA, et al. Among authors: yung wk. Int J Oncol. 2004 Feb;24(2):409-17. Int J Oncol. 2004. PMID: 14719118

10

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.

Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK, Fueyo J. Gomez-Manzano C, et al. Among authors: yung wk. Oncogene. 2004 Mar 11;23(10):1821-8. doi: 10.1038/sj.onc.1207321. Oncogene. 2004. PMID: 15014451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters